ALX Oncology Holdings Financial Overview
ALX Oncology Holdings's market cap is currently $78.62M. The company's EPS TTM is $-0.41; its P/E ratio is -0.72; ALX Oncology Holdings is scheduled to report earnings on November 7, 2025, and the estimated EPS forecast is $-0.36. See an overview of income statement, balance sheet, and cash flow financials.
